MARKET

MRK

MRK

Merck & Co
NYSE

Real-time Quotes | Nasdaq Last Sale

92.09
-0.01
-0.01%
After Hours: 92.10 +0.01 +0.01% 19:49 05/19 EDT
OPEN
91.25
PREV CLOSE
92.10
HIGH
92.61
LOW
90.88
VOLUME
11.12M
TURNOVER
160.90M
52 WEEK HIGH
94.56
52 WEEK LOW
69.54
MARKET CAP
232.88B
P/E (TTM)
16.79
1D
5D
1M
3M
1Y
5Y
Antibiotic resistance efforts get a boost as CARB-X gets $370M
Kevin Outterson has spent the better part of the last year in conversations with CARB-X's previous backers. Now, those efforts have yielded fruit: The organization has another $370 million to invest in research targeting drug-resistant bacteria.
American City Business Journals · 8h ago
4 Large Drug Stocks to Watch as the Industry Recovers
Drug/biotech companies are likely to see significant advances in innovation in 2022. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Glaxo (GSK) are worth retaining in your portfolio.
Zacks · 13h ago
12 Best DOW Stocks To Buy According To Hedge Funds
In this article, we will discuss the 12 best DOW stocks to buy according to hedge funds. If you want to explore similar stock options, you can also take a look at 5 Best DOW Stocks To Buy According To Hedge Funds. The Dow Jones Industrial Average is a pric...
Insider Monkey · 14h ago
Merck (MRK) Outperforms Industry This Year So Far: Here's Why
Strong sales of key products like Keytruda and Gardasil, a significant contribution from Lagevrio and positive pipeline/regulatory developments have been keeping Merck's (MRK) stock afloat in 2022.
Zacks · 14h ago
Bayer, Merck's Verquvo gets approval in China to treat certain patients with heart failure
China's National Medical Products Administration approved Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) and Merck's (MRK) Verquvo to treat to treat certain patients with heart failure (HF). Verquvo (vericiguat ) can now be used in China to reduce
Seekingalpha · 18h ago
Merck & Co Whale Trades For May 18
Someone with a lot of money to spend has taken a bearish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Benzinga · 1d ago
Merck in up to $1.4B licensing deal with China's Kelun Pharma for cancer candidate
Sichuan Kelun Pharmaceutical has outlicensed a large molecule oncology candidate to Merck (NYSE:MRK) in a deal worth up to $1.4B. The name of the candidate was not disclosed nor what
Seekingalpha · 1d ago
Pfizer (PFE) Gets EUA for Use of Comirnaty Booster in Children
Pfizer (PFE) and partner BioNTech gets authorization for emergency use of booster dose of its COVID-19 vaccine, Comirnaty, in children aged between 5 years and 11 years.
Zacks · 1d ago
More
No Data
Learn about the latest financial forecast of MRK. Analyze the recent business situations of Merck & Co through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 30 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

16.67%Strong Buy
50.00%Buy
33.33%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average MRK stock price target is 96.06 with a high estimate of 115.00 and a low estimate of 76.00.
High115.00
Average96.06
Low76.00
Current 92.09
EPS
Actual
Estimate
0.541.071.612.14
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 3.54K
Institutional Holdings: 2.02B
% Owned: 80.06%
Shares Outstanding: 2.53B
TypeInstitutionsShares
Increased
1.24K
90.58M
New
325
14.02M
Decreased
937
85.74M
Sold Out
89
9.56M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.15%
Pharmaceuticals & Medical Research
+0.51%
Key Executives
Chairman/Executive Director
Kenneth Frazier
President/Chief Executive Officer/Director
Robert Davis
President/Executive Vice President
Dean Li
Chief Financial Officer/Executive Vice President
Caroline Litchfield
Chief Human Resource Officer/Executive Vice President
Steven Mizell
Executive Vice President/Chief Information Officer
David Williams
Executive Vice President/General Counsel/Secretary
Jennifer Zachary
Executive Vice President
Sanat Chattopadhyay
Executive Vice President
Richard DeLuca
Executive Vice President
Cristal Downing
Executive Vice President
Julie Gerberding
Executive Vice President
Michael Klobuchar
Senior Vice President - Finance/Controller
Rita Karachun
Senior Vice President
Lisa LeCointe-Cephas
Other
Arpa Garay
Other
Deepak Khanna
Other
Jannie Oosthuizen
Lead Director/Independent Director
Thomas Glocer
Independent Director
Mary Coe
Independent Director
Pamela Craig
Independent Director
Risa Lavizzo-Mourey
Independent Director
Stephen Mayo
Independent Director
Paul Rothman
Independent Director
Patricia Russo
Independent Director
Christine Seidman
Independent Director
Inge Thulin
Independent Director
Kathy Warden
Independent Director
Peter Wendell
No Data
No Data
About MRK
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Webull offers kinds of Merck & Co., Inc. stock information, including NYSE:MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.